Brief: Biosergen Q4 Consolidated Net Loss At SEK 15.0 Million

Biosergen AB

31/03/2022 13:03

March 31 (Reuters) - Biosergen AB  BIOSGN.ST :
    * BIOSERGEN PUBLISHES INTERIM REPORT FOR FOURTH QUARTER 2021
    * Q4 CONSOLIDATED GROUP REVENUE SEK 8.9 MILLION
    * Q4 CONSOLIDATED NET LOSS SEK 15.0 MILLION

Source text for Eikon:  ID:nWkr7TJ4LX 
Further company coverage:  BIOSGN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))